CRT-Ds are cost-effective in patients with class 2 or 3 HF TheHeart.Org Toronto, ON - Using data from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) trial of patients with mildly symptomatic heart failure, researchers determined that cardiac resynchronization therapy defibrillators (CRT-Ds ... |
